• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathy.

作者信息

Mahler Christoph, Andrews Michael, Henson Sian M, Gnanapavan Sharmilee

机构信息

From the Department of Neurosciences (C.M., M.A., S.G.), the Royal London Hospital, Barts Health NHS Trust; and William Harvey Research Institute (S.M.H., S.G.), Barts & the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, United Kingdom.

出版信息

Neurol Neuroimmunol Neuroinflamm. 2020 May 20;7(4). doi: 10.1212/NXI.0000000000000756. Print 2020 Jul.

DOI:10.1212/NXI.0000000000000756
PMID:32434801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7251508/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7597/7251508/7b1d3dc02743/NEURIMMINFL2019026211f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7597/7251508/7b1d3dc02743/NEURIMMINFL2019026211f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7597/7251508/7b1d3dc02743/NEURIMMINFL2019026211f1.jpg

相似文献

1
Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathy.在进行性多灶性白质脑病中序贯使用白细胞介素-2和帕博利珠单抗。
Neurol Neuroimmunol Neuroinflamm. 2020 May 20;7(4). doi: 10.1212/NXI.0000000000000756. Print 2020 Jul.
2
Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.单剂量派姆单抗治疗进行性多灶性白质脑病
Neurol Neuroimmunol Neuroinflamm. 2021 May 26;8(4). doi: 10.1212/NXI.0000000000001021. Print 2021 Jul.
3
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency.帕博利珠单抗用于治疗原发性免疫缺陷所致的进行性多灶性白质脑病。
Neurol Neuroimmunol Neuroinflamm. 2019 Oct 9;6(6):e628. doi: 10.1212/NXI.0000000000000628. Print 2019 Nov.
4
Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.帕博利珠单抗治疗进行性多灶性白质脑病
N Engl J Med. 2019 Apr 25;380(17):1676-1677. doi: 10.1056/NEJMc1817193. Epub 2019 Apr 10.
5
Ineffective treatment of PML with pembrolizumab: Exhausted memory T-cell subsets as a clue?帕博利珠单抗治疗进行性多灶性白质脑病无效：耗竭的记忆性T细胞亚群是线索吗？
Neurol Neuroimmunol Neuroinflamm. 2019 Oct 9;6(6):e627. doi: 10.1212/NXI.0000000000000627. Print 2019 Nov.
6
Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: a case report.早期 natalizumab 相关的进行性多灶性白质脑病的非典型磁共振成像特征：一例报告
J Neurol Sci. 2014 May 15;340(1-2):213-4. doi: 10.1016/j.jns.2014.02.037. Epub 2014 Mar 5.
7
Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab.与那他珠单抗相关的无症状性进行性多灶性白质脑病
J Neurol. 2013 Feb;260(2):665-7. doi: 10.1007/s00415-012-6759-0. Epub 2012 Dec 5.
8
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.派姆单抗治疗进行性多灶性白质脑病。
N Engl J Med. 2019 Apr 25;380(17):1597-1605. doi: 10.1056/NEJMoa1815039. Epub 2019 Apr 10.
9
Novel treatments for progressive multifocal leukoencephalopathy.进行性多灶性白质脑病的新型治疗方法。
Br J Hosp Med (Lond). 2020 Jul 2;81(7):1-9. doi: 10.12968/hmed.2020.0093. Epub 2020 Jul 29.
10
Pembrolizumab treatment for progressive multifocal leukoencephalopathy in a patient with Human Immunodeficiency Virus infection.帕博利珠单抗治疗1例人类免疫缺陷病毒感染患者的进行性多灶性白质脑病。
Enferm Infecc Microbiol Clin (Engl Ed). 2020 Oct;38(8):396-397. doi: 10.1016/j.eimc.2019.12.008. Epub 2020 Jan 28.

引用本文的文献

1
Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China.派姆单抗治疗中国进行性多灶性白质脑病。
J Neurovirol. 2023 Dec;29(6):692-698. doi: 10.1007/s13365-023-01180-w. Epub 2023 Oct 28.
2
Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report.重组白细胞介素-2治疗进行性多灶性白质脑病的长期结果及HPyV-2特异性T细胞数量的相关增加：一例报告
Ther Adv Hematol. 2023 Oct 9;14:20406207231201721. doi: 10.1177/20406207231201721. eCollection 2023.
3
Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.

本文引用的文献

1
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency.帕博利珠单抗用于治疗原发性免疫缺陷所致的进行性多灶性白质脑病。
Neurol Neuroimmunol Neuroinflamm. 2019 Oct 9;6(6):e628. doi: 10.1212/NXI.0000000000000628. Print 2019 Nov.
2
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.派姆单抗治疗进行性多灶性白质脑病。
N Engl J Med. 2019 Apr 25;380(17):1597-1605. doi: 10.1056/NEJMoa1815039. Epub 2019 Apr 10.
3
Mechanisms of Resistance to PD-1 and PD-L1 Blockade.对PD-1和PD-L1阻断的耐药机制。
HIV 相关进行性多灶性白质脑病的检查点抑制剂治疗的前景与挑战。
Curr HIV/AIDS Rep. 2022 Dec;19(6):580-591. doi: 10.1007/s11904-022-00626-w. Epub 2022 Oct 1.
4
Pembrolizumab for the treatment of Progressive Multifocal Leukoencephalopathy (PML) in a patient with AIDS: A case report and literature review.帕博利珠单抗治疗艾滋病患者的进行性多灶性白质脑病（PML）：病例报告及文献综述
IDCases. 2022 May 20;28:e01514. doi: 10.1016/j.idcr.2022.e01514. eCollection 2022.
5
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab.序贯使用静脉注射用免疫球蛋白和帕博利珠单抗治疗进行性多灶性白质脑病。
J Neurovirol. 2022 Apr;28(2):335-338. doi: 10.1007/s13365-022-01059-2. Epub 2022 Mar 23.
6
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy.进行性多灶性白质脑病的创新治疗理念。
J Neurol. 2022 May;269(5):2403-2413. doi: 10.1007/s00415-021-10952-5. Epub 2022 Jan 7.
7
Advances in Treatment of Progressive Multifocal Leukoencephalopathy.进展性多灶性白质脑病的治疗进展。
Ann Neurol. 2021 Dec;90(6):865-873. doi: 10.1002/ana.26198. Epub 2021 Sep 7.
Cancer J. 2018 Jan/Feb;24(1):47-53. doi: 10.1097/PPO.0000000000000303.
4
Editorial: Immune Control of JC Virus Infection and Immune Failure during Progressive Multifocal Leukoencephalopathy.社论：进行性多灶性白质脑病期间JC病毒感染的免疫控制与免疫衰竭
Front Immunol. 2017 Nov 27;8:1646. doi: 10.3389/fimmu.2017.01646. eCollection 2017.
5
B cells and progressive multifocal leukoencephalopathy: search for the missing link.B细胞与进行性多灶性白质脑病：探寻缺失的环节。
Front Immunol. 2015 May 19;6:241. doi: 10.3389/fimmu.2015.00241. eCollection 2015.
6
PD-1 blockade induces responses by inhibiting adaptive immune resistance.程序性死亡受体1（PD-1）阻断通过抑制适应性免疫抵抗来诱导反应。
Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954.
7
Progressive multifocal leukoencephalopathy in patients with HIV infection.HIV感染患者的进行性多灶性白质脑病
J Neurovirol. 1998 Feb;4(1):59-68. doi: 10.3109/13550289809113482.